BioClinica, Inc. (NASDAQ:BIOC)

CAPS Rating: 1 out of 5

Results 1 - 3 of 3

Recs

0
Member Avatar TSIF (99.96) Submitted: 2/8/2016 1:26:21 PM : Underperform Start Price: $1.56 BIOC Score: +9.87

Erratic and holding up well under the bio-carnage. The agreement with BCBS to allow members to use the diagnostics was a boost. I'm not clear however how many "liquid biopsies" will be ordered by doctors and it appears the growing pains are excessive to offer the services... with a P/S of 61, apparently it's not that popular.

When you have a revenue of half a million a year, a loss of $16M a year and cash of $12M a year...and when you're a sub $30M company and no one else values what you do....it's really hard to get validation...so while short term "news" pops may rattle the shorts, there isn't much here to hold this valuation level....

Target...slightly over a $1.

Recs

0
Member Avatar ztrader350z (< 20) Submitted: 1/19/2016 10:18:34 AM : Outperform Start Price: $1.39 BIOC Score: +2.10

bioc

Recs

0
Member Avatar SmartAce (99.90) Submitted: 1/13/2016 3:49:10 PM : Underperform Start Price: $1.57 BIOC Score: +8.78

If you know how many cupcakes I'm holding behind my back I'll give you both of them.

Results 1 - 3 of 3

Featured Broker Partners